Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!

Product Image
Product Description

Designed specifically for the SpectraMax® i3 Multi-Mode Detection Platform, the field-upgradeable SpectraMax MiniMax™ 300 Imaging Cytometer option enables quick inspection of cells and provides insight into phenotypic changes that are important for understanding cytotoxicity, cell proliferation, and protein expression.

The SpectraMax® MiniMax™ 300 Imaging Cytometer option offers cellular imaging capability, and much more:

  • Simplified workflow: Cell and whole-well assays in a small footprint
  • No Stain Analysis: Eliminate cell staining for cell counting and confluency measurements using StainFree™ Technology
  • More data: Multi-parametric cell-based assays with brightfield and green and red fluorescent imaging
  • Familiar software: Set up, image and analyze cells in a snap using SoftMax® Pro Microplate Data Acquisition & Analysis Software
  • Higher sensitivity: Easily measure low cell concentration samples
  • Lower variance: Normalize your plate data to the number of cells in each well

The SpectraMax MiniMax™ 300 enables the following applications:

  • Cell Count/Viability
  • Cell Proliferation/Cytotoxicity
  • Marker Expression

Imaging cell-based assays typically requires the use of fluorescent probes that can be toxic to living cells or may require fixation. A label-free method for analyzing cell counts and cell confluence enables researchers to quantitatively monitor cell proliferation and health without time-consuming workflows that may disrupt cell viability.

The SpectraMax® i3 Multi-Mode Microplate Platform with MiniMax™ 300 Imaging Cytometer uses StainFree™ Cell Detection Technology so that you can perform cell proliferation, cytotoxicity, and other assays without fluorescent labels. For assays requiring multi-color detection and analysis, the SpectraMax MiniMax Imaging Cytometer now offers two channels of fluorescence, along with new cell analysis and classification methods.

This versatility is powered by SoftMax® Pro software with novel algorithms for object recognition providing multi-parametric outputs for a wide range of cell-based assays. An intuitive user interface lets even non-imaging specialists to get up and running quickly.

In our poster we demonstrate how this platform can be used to obtain more biologically relevant data. StainFree Technology enables cell counting comparable to fluorescent nuclear counts. IC50 curves for compound-treated cells obtained through StainFree analysis are presented. Cell viability assessment using the EarlyTox™ Cell Integrity assay plus
classification feature in SoftMax Pro software provide detailed information on compound
effects. Plate reader assays using luminescence or other detection modes of the
SpectraMax i3 platform can easily be combined with imaging cytometry to obtain more
information on the mechanisms of cell toxicity.

Click the more information link to register to download our poster and data sheet and imagine the possibilities.

SpectraMax-MiniMax-Datasheet-rev-C-(MiniMax-300)-1-Image-300w-web.jpg

Product SpectraMax® MiniMax™ 300 Imaging Cytometer – Don’t just read – visualize!
Company Molecular Devices
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Molecular Devices
660 - 665 Eskdale Road Winnersh Triangle Wokingham Berkshire RG41 5TS

Tel: +44-118-944-8000
Fax: +44-118-944-8001
Email: infoboxeu@moldev.com



Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!